Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography, and the nuclear imaging modalities of PET and SPECT.

AI for opportunistic osteoporosis screening inks FDA clearance
The tool analyzes routine hip and pelvis X-rays for signs of low bone mineral density.
Radiology providers missing the mark when screening disabled women for breast cancer
Only 43% of women with disabilities receive American Society of Breast Surgeons-recommended mammography screening services, according to a new single-center study.
Short-term breast cancer risk prediction improves when AI combines imaging with personal info
Understanding which women have the greatest short-term risk could enable providers to implement targeted screening strategies to ensure malignancies are caught at the earliest possible stage.
Medicare opts not to make CT radiation-related quality measure mandatory in 2027
The measure evaluates the proportion of scans that exceed certain thresholds for image noise or radiation dose across 18 categories.
Emphysema on baseline lung cancer CT a sign of future mortality risk
“Lung cancer screening shouldn’t just be looking for nodules. That’s a small part of what we see on the CT scan.”

Oligomerix’s anti-tau therapy prospectus to be presented this month

Alzheimer’s therapeutics company Oligomerix announced June 30 that Oligomerix representatives will be presenting the company’s drug development program during poster and scientific sessions at the upcoming Federation of European Neuroscience Societies (FENS) Forum of Neuroscience and the Alzheimer's Association International Conference (AAIC).

Global companion diagnostics market reached $26B last year and growing

The market for companion diagnostics was valued at $26 billion in 2013 and is projected to grow at an annual growth rate of 22.9 percent during the next decade, according to a new market research report published in June and announced by Research and Markets.

Angiogenic gene therapy shows promise in phase III SPECT study

Taxus Cardium Pharmaceuticals Group have announced encouraging interim phase III cardiac SPECT imaging results from the international ASPIRE (Efficacy and Safety of Ad5FGF-4 for Myocardial Ischemia in Patients With Stable Angina Due to Coronary Artery Disease) trial. Generx Ad5FGF-4 is a potential angiogenic gene therapy for the development of new vascularization. The data was presented June 24 during the 2014 BIO International Convention in the company’s home base of San Diego.

Sofie and PerkinElmer to market preclinical hybrids, biopharmaceuticals

PerkinElmer announced an agreement with Sofie Biosciences this month to commercialize the latter's preclinical PET, 3D CT and X-ray systems.

NCM and ImaginAb to commercialize Zr-89

New York City-based PET radiopharmaceutical development company NCM USA announced this month that ImaginAb will be working on labeling zirconium-89 (Zr-89) and manufacturing practice in a new long-term contract with NCM. 

UT Austin produces alternative means of enriching targets

The University of Texas Austin announced yesterday that a new method for enriching targets for medical isotopes has been developed and patented.

Breast Imaging market could rise to $3B by 2019

A market report on breast imaging technologies published this month by research firm Markets and Markets forecasts growth in breast imaging to approximately $3 billion in the next five years.

Moving past monetary incentive: Repurposing approved drugs for Alzheimer's

There may be drugs at the industry's fingertips, already approved, that could be of value in treating patients with neurodegenerative disease if repurposed and brought to regulatory approval for expanded indications, but these may be stalled due to rundown patents and a lack of financial incentive in the market, according the a study published June 24 in the Annals of Clinical and Translational Neurology.

Medical Imaging

AI for opportunistic osteoporosis screening inks FDA clearance

Radiology providers missing the mark when screening disabled women for breast cancer

Short-term breast cancer risk prediction improves when AI combines imaging with personal info

Medicare opts not to make CT radiation-related quality measure mandatory in 2027

Emphysema on baseline lung cancer CT a sign of future mortality risk